These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37795855)

  • 21. Combinatorial Engineering of
    Huang H; Yu W; Xu X; Liu Y; Li J; Du G; Lv X; Liu L
    ACS Synth Biol; 2024 Jun; 13(6):1866-1878. PubMed ID: 38836566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced production of 2'-fucosyllactose in engineered Escherichia coli BL21star(DE3) by modulation of lactose metabolism and fucosyltransferase.
    Chin YW; Kim JY; Lee WH; Seo JH
    J Biotechnol; 2015 Sep; 210():107-15. PubMed ID: 26193630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved production of 2'-fucosyllactose in engineered Escherichia coli by expressing putative α-1,2-fucosyltransferase, WcfB from Bacteroides fragilis.
    Chin YW; Kim JY; Kim JH; Jung SM; Seo JH
    J Biotechnol; 2017 Sep; 257():192-198. PubMed ID: 27919692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic engineering of Escherichia coli for the production of 2'-fucosyllactose and 3-fucosyllactose through modular pathway enhancement.
    Huang D; Yang K; Liu J; Xu Y; Wang Y; Wang R; Liu B; Feng L
    Metab Eng; 2017 May; 41():23-38. PubMed ID: 28286292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycosyltransferase from
    Chen G; Wu H; Zhu Y; Wan L; Zhang W; Mu W
    J Agric Food Chem; 2022 Feb; 70(6):1934-1942. PubMed ID: 34989571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2'-Fucosyllactose production in engineered Escherichia coli with deletion of waaF and wcaJ and overexpression of FucT2.
    Lee JW; Kwak S; Liu JJ; Yun EJ; Jin YS
    J Biotechnol; 2021 Nov; 340():30-38. PubMed ID: 34450187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combinatorial metabolic engineering of Escherichia coli for de novo production of 2'-fucosyllactose.
    Lin L; Gong M; Liu Y; Li J; Lv X; Du G; Liu L
    Bioresour Technol; 2022 May; 351():126949. PubMed ID: 35257882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-Titer
    Parschat K; Schreiber S; Wartenberg D; Engels B; Jennewein S
    ACS Synth Biol; 2020 Oct; 9(10):2784-2796. PubMed ID: 32966739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced bioproduction of fucosylated oligosaccharide 3-fucosyllactose in engineered Escherichia coli with an improved de novo pathway.
    Ni Z; Wu J; Li Z; Yuan L; Wang Y; Chen X; Yao J
    Biosci Biotechnol Biochem; 2021 Jun; 85(7):1772-1781. PubMed ID: 33904902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient Biosynthesis of Difucosyllactose
    Liang S; He Z; Liu D; Yang S; Yan Q; Jiang Z
    J Agric Food Chem; 2024 Feb; 72(8):4367-4375. PubMed ID: 38374607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combinatorial metabolic engineering and tolerance evolving of Escherichia coli for high production of 2'-fucosyllactose.
    Sun X; Peng Z; Li C; Zheng Y; Cheng Y; Zong J; Lu F; Li Y; Li Q
    Bioresour Technol; 2023 Mar; 372():128667. PubMed ID: 36702325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-level metabolic engineering of Escherichia coli for high-titer biosynthesis of 2'-fucosyllactose and 3-fucosyllactose.
    Li M; Li C; Luo Y; Hu M; Liu Z; Zhang T
    Microb Biotechnol; 2022 Dec; 15(12):2970-2981. PubMed ID: 36134689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineered Bacillus subtilis for the de novo production of 2'-fucosyllactose.
    Zhang Q; Liu Z; Xia H; Huang Z; Zhu Y; Xu L; Liu Y; Li J; Du G; Lv X; Liu L
    Microb Cell Fact; 2022 Jun; 21(1):110. PubMed ID: 35655274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-level production of 3-hydroxypropionic acid from glycerol as a sole carbon source using metabolically engineered Escherichia coli.
    Kim JW; Ko YS; Chae TU; Lee SY
    Biotechnol Bioeng; 2020 Jul; 117(7):2139-2152. PubMed ID: 32227471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous production of 2'-fucosyllactose and difucosyllactose by engineered Escherichia coli with high secretion efficiency.
    Lee HJ; Shin DJ; Han K; Chin YW; Park JP; Park K; Choi CH; Park BR; Kim SJ; Kim SK
    Biotechnol J; 2022 Mar; 17(3):e2100629. PubMed ID: 35073455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spatial organization of pathway enzymes via self-assembly to improve 2'-fucosyllactose biosynthesis in engineered Escherichia coli.
    Chen R; Wan L; Zhu Y; Liu Y; Zhang W; Mu W
    Biotechnol Bioeng; 2023 Feb; 120(2):524-535. PubMed ID: 36326175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of a human milk oligosaccharide 2'-fucosyllactose by metabolically engineered Saccharomyces cerevisiae.
    Yu S; Liu JJ; Yun EJ; Kwak S; Kim KH; Jin YS
    Microb Cell Fact; 2018 Jun; 17(1):101. PubMed ID: 29950173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbial Synthesis of l-Fucose with High Productivity by a Metabolically Engineered
    Meng J; Zhu Y; Chen R; Liu Y; Zhang W; Mu W
    J Agric Food Chem; 2023 Feb; 71(5):2464-2471. PubMed ID: 36700831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved production of 2'-fucosyllactose in engineered Saccharomyces cerevisiae expressing a putative α-1, 2-fucosyltransferase from Bacillus cereus.
    Xu M; Meng X; Zhang W; Shen Y; Liu W
    Microb Cell Fact; 2021 Aug; 20(1):165. PubMed ID: 34425826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineering the productivity of recombinant Escherichia coli for limonene formation from glycerol in minimal media.
    Willrodt C; David C; Cornelissen S; Bühler B; Julsing MK; Schmid A
    Biotechnol J; 2014 Aug; 9(8):1000-12. PubMed ID: 24756896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.